Skip to main content

Relias Media has upgraded our site!

Please bear with us as we work through some issues in order to provide you with a better experience.

Thank you for your patience.

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

<p>The checkpoint inhibitor nivolumab failed a Phase III trial as monotherapy in patients with previously untreated non-small cell lung cancer.</p>

Top Pharmaceutical Company Suffers Blow After Major Drug Fails Phase III Trial